The powerful Novo Nordisk Foundation, the largest shareholder in pharmaceutical giant Novo Nordisk, has executed a dramatic boardroom takeover after a sharp disagreement about the company’s strategic direction. The move,
The powerful Novo Nordisk Foundation, the largest shareholder in pharmaceutical giant Novo Nordisk, has executed a dramatic boardroom takeover after a sharp disagreement about the company’s strategic direction. The move,






